Anti-lipid oligoclonal IgM bands contribute to progressive multifocal leukoencephalopathy (PML) risk stratification in multiple sclerosis patients treated with natalizumab
Publication date:
2013
Publisher version:
Descripción física:
p. 56-57
Description:
Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (29th, 2013, Copenhagen)
Identificador local:
20141123
